manag
patient
flow
bed
alloc
import
element
effect
infect
control
programm
viral
influenza
infect
effect
programm
requir
result
screen
test
avail
make
decis
time
manner
suit
flow
newli
admit
patient
hospit
difficult
laboratorybas
test
especi
weekend
even
limit
oncal
servic
may
avail
nick
enzym
nucleic
acid
near
isotherm
amplif
techniqu
enabl
rapid
amplif
narrow
temperatur
rang
elimin
need
thermal
cycler
hightemperatur
dna
denatur
cycl
requir
polymeras
chain
reaction
pcr
lowfootprint
benchtop
instrument
provid
result
min
nearpati
set
previous
demonstr
poct
lead
rapid
confirm
influenza
allow
inform
earli
decis
make
reduc
flu
contact
bed
closur
emerg
evid
suggest
less
invas
sampl
may
compar
sensit
nasopharyng
swab
aspir
use
molecular
diagnost
test
test
kit
util
nasal
swab
comfort
patient
eg
id
number
studi
report
outlin
perform
aler
poct
known
abbott
id
naat
versu
laboratori
base
method
thermocycl
rtpcr
viral
cultur
influenza
test
studi
report
influenza
sensit
rang
specif
influenza
b
sensit
rang
specif
studi
compar
id
genexpert
previous
use
nasopharyng
swab
viral
transport
medium
vtm
sensit
report
lower
vtm
specimen
use
instead
direct
nasal
swab
assay
also
lower
sensit
sampl
determin
low
flu
titer
determin
higher
ct
valu
rtpcr
order
better
assist
patient
flow
bed
manag
winter
prospect
assess
util
poct
id
influenza
assay
test
compar
genexpert
platform
laboratori
set
addit
impact
antibiot
antivir
prescript
compar
determin
influenc
poct
servic
element
patient
manag
consecut
flu
season
preimplement
postimplement
infect
control
algorithm
suspect
influenza
implement
pre
post
poct
test
period
studi
outlin
supplementari
inform
context
outbreak
hospit
infect
control
algorithm
suspect
access
entri
suspect
influenza
pathway
occur
rule
pathway
match
patient
specimen
collect
medic
assess
unit
bon
secour
hospit
trale
co
kerri
ireland
met
hospit
clinic
algorithm
suspect
influenza
octob
april
mid
turbin
nasal
swab
puritan
steril
foam
tip
applic
ref
test
within
h
collect
prefer
specimen
id
poct
devic
nasal
throat
specimen
analysi
genexpert
collect
use
cepheid
nasopharyng
sampl
collect
kit
virus
ref
viral
transport
medium
vtm
specimen
test
genexpert
flursv
assay
typic
store
h
routin
day
h
weekend
prior
transport
referr
laboratori
test
poct
coordin
mau
nurs
staff
medic
senior
hous
offic
sho
train
manufactur
use
id
instrument
patient
posit
influenza
result
flag
standard
droplet
precaut
isol
infect
control
team
patient
specimen
analys
test
system
per
manufactur
instruct
batch
reagent
use
valid
studi
qualiti
control
receipt
specimen
test
abbott
id
assay
within
h
collect
analysi
patient
swab
use
genexpert
platform
referr
laboratori
carri
mix
equal
volum
aliquot
vtm
nasal
throat
specimen
test
give
aggreg
sampl
genexpert
method
provid
posit
result
either
nasal
throat
swab
posit
pool
sampl
collect
detail
result
specimen
analys
use
id
manual
record
influenza
specimen
analysi
report
compil
oper
subsequ
file
patient
medic
chart
specimen
analysi
use
genexpert
sent
patholog
depart
specimen
regist
laboratori
inform
system
isoft
transfer
courier
referr
laboratori
data
gather
hospit
li
patient
inform
manag
system
pim
isoft
retrospect
interrog
use
sap
busi
object
bi
platform
version
data
patient
specimen
collect
influenza
test
septemb
april
repres
pre
poct
test
data
set
data
patient
pointofcar
influenza
test
septemb
april
repres
post
poct
implement
data
set
world
health
organis
describ
defin
daili
dose
ddd
assum
averag
mainten
dose
per
day
medicin
use
main
indic
adult
select
criteria
includ
adult
patient
confirm
diagnosi
influenza
type
b
multidisciplinari
team
review
medic
note
prescript
determin
gener
antibiot
name
dose
number
dose
cumul
dose
antibiot
administ
inpati
admiss
respect
cohort
period
accord
collabor
centr
drug
statist
methodolog
antibiot
consumpt
data
collat
analys
use
refer
valu
avail
anatom
therapeut
chemic
atc
classif
system
ddd
calcul
antimicrobi
consum
everi
patient
suitabl
cohort
entri
suitabl
statist
analysi
perform
use
microsoft
excel
add
xlstat
pvalu
consid
statist
signific
chi
squar
test
use
categor
data
total
patient
specimen
test
valid
phase
result
influenza
b
correl
present
addit
file
tabl
respect
one
discrep
result
instrument
influenza
repeat
analysi
nasal
throat
specimen
separ
genexpert
result
ct
valu
nasal
swab
throat
swab
neg
influenza
b
posit
patient
specimen
obtain
valid
period
extern
qualiti
control
scheme
sampl
intern
qualiti
control
sampl
posit
influenza
b
test
system
agreement
perform
characterist
valid
studi
present
addit
file
tabl
id
found
sensit
influenza
specif
influenza
b
obtain
sensit
specif
age
gender
profil
patient
cohort
screen
influenza
outlin
addit
file
tabl
patient
screen
season
femal
male
screen
season
averag
age
patient
screen
significantli
younger
pvalu
result
influenza
screen
retrospect
collat
season
evid
result
tabl
influenza
b
domin
strain
influenza
season
influenza
domin
incid
influenzaposit
specimen
respect
number
patient
receiv
oseltamivir
increas
addit
number
patient
receiv
oseltamivir
result
posit
influenza
screen
test
also
increas
averag
defin
daili
dose
ddd
antibiot
cohort
patient
found
reduc
implement
infect
control
measur
patient
isol
cohort
influenzaposit
patient
increas
statist
signific
p
reduct
averag
bed
stay
observ
averag
bed
night
sampl
adult
year
influenzaposit
patient
chart
season
review
evprofil
patient
cohortalu
profil
defin
daili
dose
antibiot
administ
tabl
evid
result
signific
reduct
number
antibiot
dose
prescrib
versu
p
total
differ
antibiot
use
found
reduc
concurr
reduct
total
number
dose
consum
patient
cohort
studi
larger
patient
popul
would
use
demonstr
reproduc
studi
potenti
lead
signific
cost
save
better
bed
manag
peak
influenza
season
effect
variabl
individu
prescrib
prefer
antibiot
laboratori
cultur
sensit
late
patient
present
hospit
statist
signific
antibiot
usag
pattern
varianc
cohort
note
